Fidelity Investments
FLNA

Fidelity Investments’s Filana Therapeutics FLNA Stock Holding History

Fidelity Investments’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.46K Sell
2,904
-3,158
-52% -$4.5K ﹤0.01% 5085
2026
Q1 		$10.2K Sell
6,062
-1,430
-19% -$2.94K ﹤0.01% 4763
2025
Q4 		$14.8K Sell
7,492
-1,149
-13% -$3.68K ﹤0.01% 4592
2025
Q3 		$25.1K Buy
8,641
+65
+0.8% +$149 ﹤0.01% 4267
2025
Q2 		$15.5K Sell
8,576
-2,417
-22% -$4.3K ﹤0.01% 4379
2025
Q1 		$16.5K Sell
10,993
-80,157
-88% -$202K ﹤0.01% 4300
2024
Q4 		$215K Buy
91,150
+90,033
+8,060% +$1.58M ﹤0.01% 3238
2024
Q3 		$32.9K Sell
1,117
-242
-18% -$5.57K ﹤0.01% 3964
2024
Q2 		$16.8K Sell
1,359
-10,429
-88% -$220K ﹤0.01% 4138
2024
Q1 		$239K Buy
11,788
+9,752
+479% +$225K ﹤0.01% 2976
2023
Q4 		$45.8K Sell
2,036
-2,986
-59% -$63.1K ﹤0.01% 3556
2023
Q3 		$83.6K Buy
5,022
+2,880
+134% +$57.1K ﹤0.01% 3159
2023
Q2 		$52.5K Buy
2,142
+474
+28% +$11.4K ﹤0.01% 3411
2023
Q1 		$40.2K Sell
1,668
-2,982
-64% -$82.6K ﹤0.01% 3544
2022
Q4 		$137K Sell
4,650
-305
-6% -$11K ﹤0.01% 3109
2022
Q3 		$207K Buy
4,955
+4,385
+769% +$118K ﹤0.01% 3042
2022
Q2 		$16K Sell
570
-40
-7% -$1.01K ﹤0.01% 3968
2022
Q1 		$23K Buy
+610
New +$25.8K ﹤0.01% 3960
2021
Q3 		– Sell
-5
Closed – – 4940
2021
Q2 		$0 Sell
5
-2,749
-100% -$147K ﹤0.01% 4791
2021
Q1 		$124K Buy
+2,754
New +$108K ﹤0.01% 2896
2019
Q3 		– Sell
-1,000
Closed -$1K – 4180
2019
Q2 		$1K Buy
+1,000
New +$1.13K ﹤0.01% 3634
2014
Q4 		– Sell
-2,857
Closed -$78K – 2830
2014
Q3 		$78K Sell
2,857
-17,960
-86% -$546K ﹤0.01% 2757
2014
Q2 		$838K Hold
20,817
– – ﹤0.01% 2533
2014
Q1 		$801K Sell
20,817
-12,585
-38% -$444K ﹤0.01% 2501
2013
Q4 		$1.14M Hold
33,402
– – ﹤0.01% 2435
2013
Q3 		$636K Sell
33,402
-418
-1% -$7.31K ﹤0.01% 2490
2013
Q2 		$523K Buy
+33,820
New +$715K ﹤0.01% 2474

Other funds holding FLNA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Fidelity Investments's FLNA Position: Q2 2026 in Review

Fidelity Investments reduced its Filana Therapeutics (FLNA) stake by 52% in Q2 2026, selling an estimated $4.5K and leaving 2,904 shares worth $3.46K. The position accounts for ﹤0.01% of the portfolio, ranked #5085.

Fidelity Investments first reported a position in FLNA in Q2 2013 and has held it in 27 quarters since. The position peaked at $1.14M in Q4 2013. 84 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • Fidelity Investments held 2,904 shares of Filana Therapeutics worth $3.46K as of Q2 2026.
  • Fidelity Investments sold 3,158 Filana Therapeutics shares in Q2 2026, an estimated $4.5K.
  • Filana Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5085 holding.
  • Fidelity Investments first reported a position in Filana Therapeutics in Q2 2013 and has held it in 27 quarters since.
  • Fidelity Investments's Filana Therapeutics position peaked at $1.14M in Q4 2013.
  • 84 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.